Countdown to Xylem (XYL) Q2 Earnings: A Look at Estimates Beyond Revenue and EPS
Werte in diesem Artikel
Wall Street analysts forecast that Xylem (XYL) will report quarterly earnings of $1.14 per share in its upcoming release, pointing to a year-over-year increase of 4.6%. It is anticipated that revenues will amount to $2.21 billion, exhibiting an increase of 2.1% compared to the year-ago quarter.Over the last 30 days, there has been an upward revision of 0.2% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe.Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.While it's common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during the quarter, exploring analysts' forecasts for key metrics can yield valuable insights.That said, let's delve into the average estimates of some Xylem metrics that Wall Street analysts commonly model and monitor.Analysts predict that the 'Revenue- Measurement & Control Solutions' will reach $509.46 million. The estimate points to a change of +5.7% from the year-ago quarter.The consensus estimate for 'Revenue- Applied Water' stands at $459.40 million. The estimate suggests a change of +0.8% year over year.It is projected by analysts that the 'Revenue- Water Infrastructure' will reach $639.53 million. The estimate points to a change of +1.4% from the year-ago quarter.The average prediction of analysts places 'Revenue- Water Solutions and Services' at $605.08 million. The estimate indicates a change of +0.9% from the prior-year quarter.Analysts expect 'Adjusted Operating Income- Water Infrastructure' to come in at $124.64 million. Compared to the present estimate, the company reported $101.00 million in the same quarter last year.The collective assessment of analysts points to an estimated 'Adjusted Operating Income- Applied Water' of $80.10 million. Compared to the current estimate, the company reported $73.00 million in the same quarter of the previous year.Based on the collective assessment of analysts, 'Adjusted Operating Income- Water Solutions and Services' should arrive at $98.21 million. Compared to the current estimate, the company reported $99.00 million in the same quarter of the previous year.The consensus among analysts is that 'Adjusted Operating Income- Measurement & Control Solutions' will reach $84.05 million. The estimate compares to the year-ago value of $96.00 million. View all Key Company Metrics for Xylem here>>> Over the past month, shares of Xylem have returned +3.4% versus the Zacks S&P 500 composite's +4.9% change. Currently, XYL carries a Zacks Rank #3 (Hold), suggesting that its performance may align with the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .5 Stocks Set to DoubleEach was handpicked by a Zacks expert as the favorite stock to gain +100% or more in the months ahead. They includeStock #1: A Disruptive Force with Notable Growth and ResilienceStock #2: Bullish Signs Signaling to Buy the DipStock #3: One of the Most Compelling Investments in the MarketStock #4: Leader In a Red-Hot Industry Poised for GrowthStock #5: Modern Omni-Channel Platform Coiled to SpringMost of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor. While not all picks can be winners, previous recommendations have soared +171%, +209% and +232%.Download Atomic Opportunity: Nuclear Energy's Comeback free today.Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Xylem Inc. (XYL): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Übrigens: Q2 und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.
Ausgewählte Hebelprodukte auf Q2
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Q2
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu Xylem Inc.
Analysen zu Xylem Inc.
Datum | Rating | Analyst | |
---|---|---|---|
14.05.2019 | Xylem Market Perform | Cowen and Company, LLC | |
19.12.2018 | Xylem Buy | Stifel, Nicolaus & Co., Inc. | |
04.08.2017 | Xylem Outperform | BMO Capital Markets | |
02.08.2017 | Xylem Outperform | RBC Capital Markets | |
23.06.2017 | Xylem Outperform | BMO Capital Markets |
Datum | Rating | Analyst | |
---|---|---|---|
19.12.2018 | Xylem Buy | Stifel, Nicolaus & Co., Inc. | |
04.08.2017 | Xylem Outperform | BMO Capital Markets | |
02.08.2017 | Xylem Outperform | RBC Capital Markets | |
23.06.2017 | Xylem Outperform | BMO Capital Markets | |
15.05.2017 | Xylem Overweight | Barclays Capital |
Datum | Rating | Analyst | |
---|---|---|---|
14.05.2019 | Xylem Market Perform | Cowen and Company, LLC | |
01.02.2017 | Xylem Hold | Gabelli & Co | |
04.05.2016 | Xylem Neutral | Wedbush Morgan Securities Inc. | |
11.04.2016 | Xylem Neutral | Wedbush Morgan Securities Inc. | |
02.11.2015 | Xylem Equal Weight | Barclays Capital |
Datum | Rating | Analyst | |
---|---|---|---|
Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar. Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Xylem Inc. nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen